German testicular cancer thrombosis register study

German testicular cancer thrombosis register study - TEK-Register study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00012995

Enrollment

450

Registered

2018-04-23

Start date

2015-01-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C62

Interventions

Group 1: Data on incidence of chemotherapy-associated thrombosis during chemotherapy of testicular cancer patients only exist from retrospective studies. This multicentre, prospective register study i

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Chemotherapy due to testicular cancer

Exclusion criteria

Exclusion criteria: Simultaneous or previous malignant diseases; Age <18 years; Female or intersexuality

Design outcomes

Primary

Measure	Time frame
Incidence of thromboembolic complications during and up to one year after completing chemotherapy.	—

Secondary

Measure	Time frame
Evaluation of potential risk factors; Localization of thrombosis; Consequences of thrombosis (e.g., cessation of chemotherapy). Study-related interventions are an interview before starting chemotherapy and a telephone interview one year after completing chemotherapy.	—

Countries

Germany

Contacts

Public ContactTim Nestler

Bundeswehrzentralkrankenhaus KoblenzKlinik für Urologie

timnestler@bundeswehr.org02612813101

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026